Aurora Cannabis Inc.
ACB
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $244.7M
$3.95
▲ +1.54%
P/E
-5.62
Mkt Cap
$244.7M
52-Wk Range
$2.56–$6.67
52-Week Range
$2.56 - $6.67
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 18.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Vertically integrated operations from breeding to retail distribution
- Diverse portfolio of established cannabis brands with strong market recognition
- Advanced facility engineering and cannabis breeding capabilities
- Medical cannabis expertise through CanvasRX counseling centers and patient services
Bear Case
1 risk
- Average volatility.
Growth
Moderate growth ahead
International cannabis market expansion into new jurisdictions
Value
Deep value opportunity - significant discount to Large Cap Pharma peers
Momentum
Strong
+15.8% over 3m
Quality
Stable
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying ACB right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of $0.04 vs -$0.13 consensus (+130.8% surprise). Revenue of $47.6M vs $47.4M expected (+0.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+130.8%
Revenue trend · last 8Q
—
—
—
+34%
+6%
+11%
+7%
+2%
Q1 24
Q2 24
Q3 24
Q4 25
Q1 25
Q2 25
Q3 25
Q1 27
$44.2M
$42.9M
$46.7M
$47.9M
$46.7M
$47.8M
$49.8M
$49.1M
Margins · last 8Q
Gross
—
Operating
—
Profit
-6.0%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How ACB stacks vs Drug Manufacturers - Specialty & Generic
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related